The future of AI drug discovery & development in immunology and GPCR research
pharmaphorum
SEPTEMBER 16, 2022
The purpose of collaborating with Sosei Heptares, Kim told pharmaphorum, was to streamline definition of those GPCR targets worth studying, while substantially reducing human hours spent trawling through data. Verily’s Immune Profiler can, Kim asserted, “generate more than 8 million immune measures across 24 immune cell subsets”.
Let's personalize your content